Neurones Stock

Neurones EBIT

The EBIT of Neurones (NRO.PA) as of Aug 6, 2026 is 72.33 M EUR. In the previous year, EBIT was 77.90 M EUR — a change of -7.15% (lower).

EBIT

72.33 MEUR

YoY

-7.15%

Last updated:

In 2026, Neurones's EBIT was 72.33 M EUR, a -7.15% increase from the 77.90 M EUR EBIT recorded in the previous year.

The Neurones EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M EUR)
Date
EBIT (M EUR)
Jan 1, 2021
61.57 base
Jan 1, 2022
72.89 base
Jan 1, 2023
75.86 base
Jan 1, 2024
77.90 base
Jan 1, 2025
72.33 base
Jan 1, 2026 (e)
91.44 base
Jan 1, 2027 (e)
96.01 base
Jan 1, 2028 (e)
100.33 base
YEAREBIT (M EUR)
2028 est 100.33
2027 est 96.01
2026 est 91.44
2025 72.33
2024 77.90
2023 75.86
2022 72.89
2021 61.57
2020 53.75
2019 53.99
2018 45.96
2017 44.87
2016 42.51
2015 37.07
2014 35.54
2013 32.89
2012 28.07
2011 26.29
2010 24.55
2009 19.06
2008 18.41
2007 13.84
2006 8.98
Access this data via the Eulerpool API

Neurones Revenue

Neurones Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
579.88 M EUR
61.57 M EUR
37.71 M EUR
Jan 1, 2022
665.38 M EUR
72.89 M EUR
44.24 M EUR
Jan 1, 2023
741.18 M EUR
75.86 M EUR
49.41 M EUR
Jan 1, 2024
810.40 M EUR
77.90 M EUR
52.50 M EUR
Jan 1, 2025
857.20 M EUR
72.33 M EUR
52.07 M EUR
Jan 1, 2026 (e)
904.35 M EUR
91.44 M EUR
56.68 M EUR
Jan 1, 2027 (e)
949.56 M EUR
96.01 M EUR
62.72 M EUR
Jan 1, 2028 (e)
992.29 M EUR
100.33 M EUR
68.97 M EUR

Neurones Margins

Neurones stock margins

The Neurones margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Neurones. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Neurones.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
12.03 %
10.62 %
6.50 %
Jan 1, 2022
12.27 %
10.96 %
6.65 %
Jan 1, 2023
46.78 %
10.23 %
6.67 %
Jan 1, 2024
47.97 %
9.61 %
6.48 %
Jan 1, 2025
10.50 %
8.44 %
6.07 %
Jan 1, 2026 (e)
10.50 %
10.11 %
6.27 %
Jan 1, 2027 (e)
10.50 %
10.11 %
6.60 %
Jan 1, 2028 (e)
10.50 %
10.11 %
6.95 %

Neurones Stock analysis

What does Neurones do? Neurones SA is a French company specializing in IT services and consulting. It was founded in 1989 and is based in Paris. With over 10,000 employees worldwide, the company operates in over 20 countries and serves clients in various industries such as healthcare, finance, telecommunications, and the public sector. Neurones SA's business model is based on developing and implementing IT projects and providing consulting and support services tailored to its clients' specific needs. The company's divisions include management consulting, system integration, maintenance, and technology services. Its product portfolio includes solutions in CRM, ERP, CMS, as well as cloud computing, cybersecurity, and data analytics. Neurones SA's key products are the Neurones AI Suite, which utilizes AI and machine learning to automate business processes and improve decision-making, and the Smart Health Platform, a cloud-based platform for the healthcare industry. The company's clients include Air France, L'Oréal, PSA Peugeot Citroën, and Orange. Neurones SA emphasizes customer loyalty, with over 80% of its clients being long-term customers. Overall, Neurones SA is a leading IT company that specializes in providing tailored IT solutions and consulting services, and it is well-positioned for future success with its global presence and diverse range of products and services. Neurones is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Neurones's EBIT

Neurones's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Neurones's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Neurones's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Neurones’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Neurones stock

EBIT of Neurones is 72.33 M EUR in 2026.

EBIT of Neurones changed from 77.90 M EUR to 72.33 M EUR, representing a -7.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Neurones since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Neurones historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Neurones

All Key Metrics — Neurones